News & Trends - Pharmaceuticals
No scientific evidence to support claims ibuprofen worsens COVID-19
The Therapeutic Goods Administration (TGA) is aware of anecdotal reports circulating in the media of an association between the use of ibuprofen (a non-steroidal anti-inflammatory drug, or NSAID) and worse outcomes in patients with COVID-19.
The European Medicines Agency (EMA) also became aware of reports, especially on social media, which raised questions about whether non-steroidal anti-inflammatory medicines (NSAIDs) such as ibuprofen could worsen coronavirus disease (COVID-19).
The warning by French Health Minister Olivier Veran followed a recent study in The Lancet medical journal that hypothesised that an enzyme boosted by anti-inflammatory drugs such as ibuprofen could facilitate and worsen COVID-19 infections.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
The TGA investigated this safety concern and found that there is currently no published peer-reviewed scientific evidence to support a direct link between use of ibuprofen and more severe infection with COVID-19. The TGA will continue to monitor this issue.
The EMA spokesperson said “There is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID‑19. EMA is monitoring the situation closely and will review any new information that becomes available on this issue in the context of the pandemic.”
Human Resources
Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day
People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]
MoreNews & Trends - MedTech & Diagnostics
Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation
MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]
MoreNews & Trends - MedTech & Diagnostics
Federal budget delivers ‘mixed news’ for radiologists
MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]
MoreNews & Trends - Pharmaceuticals
AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers
Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]
More